文献速递痛风与晶体性关节病

一般人群中遗传决定的血浆维生素C与尿酸盐:一项纳入106147人的孟德尔随机化研究

Genetically high plasma vitamin C and urate: a Mendelian randomization study in 106 147 individuals from the general population.
PubMed 文献 · Rheumatology (Oxford) · 2018-01-01

在哥本哈根一般人群研究中纳入106147人,其中24099人有高尿酸血症,采用孟德尔随机化方法检验血浆维生素C与尿酸盐的因果关系。观察性分析显示血浆维生素C每升高10 µmol/l与尿酸盐降低2.3 µmol/l及高尿酸血症风险降低相关,但遗传变异SLC23A1 rs33972313所致终身高血浆维生素C与尿酸盐水平或高尿酸血症风险无关。结论不支持血浆维生素C高与尿酸盐低之间存在因果关系。

要点

  • 观察性分析中血浆维生素C每升高10 µmol/l,尿酸盐降低2.3 µmol/l,高尿酸血症OR为0.92。
  • SLC23A1 rs33972313 GG基因型与血浆维生素C升高9%相关,但与尿酸盐无关(P=0.31)。
  • 遗传预测的高血浆维生素C与高尿酸血症无关(OR 1.01),不支持因果关联。

核心结论

  • 观察性分析显示高血浆维生素C与低尿酸盐及低高尿酸血症风险相关,但导致终身高血浆维生素C的SLC23A1遗传变异与尿酸盐水平或高尿酸血症风险无关,数据不支持高血浆维生素C与低尿酸盐之间存在因果关系。

研究设计与样本

  • 在哥本哈根一般人群研究(Copenhagen General Population Study)的106147人中检测血浆尿酸盐并对SLC23A1 rs33972313维生素C变异进行基因分型,其中24099人有高尿酸血症。
  • 在9234人中检测血浆维生素C,并在102345人中检测SLC2A9 rs7442295尿酸盐变异。

主要发现

  • 经多变量调整后,血浆维生素C每升高10 µmol/l与血浆尿酸盐降低2.3(95%CI:-0.69至-3.9)µmol/l相关。
  • SLC23A1 rs33972313 GG基因型与AA和AG合并组相比血浆维生素C升高9%(5.6%,11.9%),但与血浆尿酸盐无关(P=0.31)。
  • 经多变量调整后观察性分析中,血浆维生素C每升高10 µmol/l,高尿酸血症的比值比为0.92(0.86,0.98),而遗传分析中为1.01(0.84,1.23)。

关键数值与推荐

  • 血浆维生素C每升高10 µmol/l与血浆尿酸盐降低2.3(95%CI:-0.69至-3.9)µmol/l相关(观察性,多变量调整后)。
  • SLC23A1 rs33972313 GG基因型与AA和AG合并组相比血浆维生素C升高9%(5.6%,11.9%)。
  • 血浆维生素C每升高10 µmol/l,高尿酸血症的比值比观察性为0.92(0.86,0.98),遗传分析为1.01(0.84,1.23)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Gout is the most common form of inflammatory arthritis and is caused by hyperuricaemia. Some studies have found a reduction in plasma urate with vitamin C supplementation. We tested the hypothesis that high plasma vitamin C is causally associated with low plasma urate and low risk of hyperuricaemia, using a Mendelian randomization approach. METHODS: We measured plasma urate and genotyped for the SLC23A1 rs33972313 vitamin C variant in 106 147 individuals from the Copenhagen General Population Study, of which 24 099 had hyperuricaemia. We measured plasma vitamin C in 9234 individuals and genotyped for the SLC2A9 rs7442295 urate variant in 102 345 individuals. RESULTS: Each 10 µmol/l higher plasma vitamin C was associated with a -2.3(95%CI: -0.69 to -3.9) µmol/l lower plasma urate after multivariable adjustments. The SLC23A1 rs33972313 GG genotype was associated with a 9% (5.6%, 11.9%) higher plasma vitamin C compared with AA and AG combined but was not associated with plasma urate (P = 0.31). Likewise, for each 10 µmol/l higher plasma vitamin C the odds ratios for hyperuricaemia were 0.92 (0.86, 0.98) observationally after multivariable adjustments, but 1.01 (0.84, 1.23) genetically. CONCLUSION: High plasma vitamin C was associated with low plasma urate and with low risk of hyperuricaemia. However, the SLC23A1 genetic variant causing lifelong high plasma vitamin C was not associated with plasma urate levels or with risk of hyperuricaemia. Thus, our data do not support a causal relationship between high plasma vitamin C and low plasma urate.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Kobylecki CJ, Afzal S, Nordestgaard BG, et al. Genetically high plasma vitamin C and urate: a Mendelian randomization study in 106 147 individuals from the general population. Rheumatology (Oxford). 2018. PMID: 29939348. doi:10.1093/rheumatology/key171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。